New Issue: UBS prices $27 million 10.5% GOALS linked to Amgen

New York, Nov. 29 - UBS AG Wednesday issued $27 million of 10.5% one-year GOALS linked to Amgen Inc. common stock.

The equity-linked notes pay a higher coupon than a regular bond in exchange for the holder participating in the downside of Amgen stock.

Underwriters were UBS Warburg and UBS PaineWebber Inc.

Issuer:	UBS AG
Maturity:	Dec. 2, 2002
Coupon:	10.5% payable semi-annually
Price:	Par of $1,000
Payment at maturity:	If Amgen shares never close below the protection price before the final
	valuation date, holders will receive 100% of principal in cash
	If Amgen shares close below the protection price before the final
	valuation date but close on the valuation date at or above the initial
	price, holders will receive 100% of principal in cash
	Otherwise holders receive 15.1860 Amgen shares with a market
	value less than 100% of principal
	The initial price is $65.85 (the closing price of Amgen on the trade date)
	The protection price is $52.68 (20% below the initial price)
	The final valuation date is three business days before maturity.
Listing:	American Stock Exchange under the symbol GPL.B
End

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.